Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride and dutasteride may increase the risk of depression and suicidality, so patients should be monitored closely.

Imuvert can prevent some chemotherapy-induced hair loss.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

The new method for making Finasteride is cheaper and safer for large-scale production.

The treatment effectively promoted hair growth with minimal side effects.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

CAL-PDT is safer and more effective for treating actinic keratosis on the scalp.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Dutasteride works better than finasteride for hair growth with similar side effects.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

5-Alpha-Reductase Inhibitors can cause negative side effects.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Finasteride and dutasteride may cause macular abnormalities.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

AVT is highly conserved and may have antimicrobial properties.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

The methods accurately measure finasteride and tadalafil in Entadfi™ capsules for quality control.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

Dutasteride is more effective than finasteride in reducing urinary retention and surgery risks in people aged 65 and older.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Dextran sulfate was found to be toxic and ineffective for treating HIV.